These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34528215)

  • 1. Systematising Pharmacovigilance Engagement of Patients, Healthcare Professionals and Regulators: A Practical Decision Guide Derived from the International Risk Governance Framework for Engagement Events and Discourse.
    Bahri P; Pariente A
    Drug Saf; 2021 Nov; 44(11):1193-1208. PubMed ID: 34528215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET).
    Bahri P; Morales DR; Inoubli A; Dogné JM; Straus SMJM
    Drug Saf; 2021 Feb; 44(2):193-209. PubMed ID: 33125664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Engagement' of patients and healthcare professionals in regulatory pharmacovigilance: establishing a conceptual and methodological framework.
    Brown P; Bahri P
    Eur J Clin Pharmacol; 2019 Sep; 75(9):1181-1192. PubMed ID: 31240364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CIOMS and ICH initiatives in pharmacovigilance and risk management: overview and implications.
    Tsintis P; La Mache E
    Drug Saf; 2004; 27(8):509-17. PubMed ID: 15154824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matching safety to access: global actors and pharmacogovernance in Kenya- a case study.
    Moscou K; Kohler JC
    Global Health; 2017 Mar; 13(1):20. PubMed ID: 28335786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coping with complexity, uncertainty and ambiguity in risk governance: a synthesis.
    Renn O; Klinke A; van Asselt M
    Ambio; 2011 Mar; 40(2):231-46. PubMed ID: 21446401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions.
    Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on: "Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)".
    Braillon A; Martin M
    Drug Saf; 2021 Sep; 44(9):1007-1009. PubMed ID: 34324173
    [No Abstract]   [Full Text] [Related]  

  • 11. Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works.
    Santoro A; Genov G; Spooner A; Raine J; Arlett P
    Drug Saf; 2017 Oct; 40(10):855-869. PubMed ID: 28735357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Assessment and Risk Governance of Liquefied Natural Gas Development in Gladstone, Australia.
    van der Vegt RG
    Risk Anal; 2018 Sep; 38(9):1830-1846. PubMed ID: 29481704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient Registries: An Underused Resource for Medicines Evaluation : Operational proposals for increasing the use of patient registries in regulatory assessments.
    McGettigan P; Alonso Olmo C; Plueschke K; Castillon M; Nogueras Zondag D; Bahri P; Kurz X; Mol PGM
    Drug Saf; 2019 Nov; 42(11):1343-1351. PubMed ID: 31302896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the decision-making process for nonprescription drugs: a framework for benefit-risk assessment.
    Brass EP; Lofstedt R; Renn O
    Clin Pharmacol Ther; 2011 Dec; 90(6):791-803. PubMed ID: 22048228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Authors' Reply to Braillon and Martin's Comment on "Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)".
    Bahri P; Morales DR; Inoubli A; Dogné JM; Straus SMJM
    Drug Saf; 2021 Sep; 44(9):1011-1013. PubMed ID: 34324172
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of Changing Regulations and the Dynamic Nature of European Risk Management Plans for Human Medicines on the Lifecycle of Safety Concerns.
    Holm JEJ; Ruppert JG; Ramsden SD
    Pharmaceut Med; 2022 Feb; 36(1):33-46. PubMed ID: 35099785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative Risk Assessment for Substandard Antibiotics Along the Manufacturing and Supply Chain: A Proof-of-Concept Study.
    Ching C; Fuzail MA; Zaman MH; Wirtz VJ
    Ther Innov Regul Sci; 2023 Jan; 57(1):121-131. PubMed ID: 36006562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.